Recursion Pharmaceuticals RXRX
$2.45 −$0.27 (-9.93%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $2.51 +2.39%
Open$2.63
Prev close$2.72
Day range$2.44 – $2.76
Volume29.88M
Market cap$1.53B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts4
Average target$6.63+170.6% vs. price
- Buy 50%
- Hold 50%
Low $5.90Now $2.45Avg $6.63High $8.00
Recent rating changes
The last 20 actions on file set price targets from $5.30 to $10.00, averaging $6.71.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 4 Nov 2026 | BofA Securities | HOLD | $6.00 |
| 19 Oct 2026 | Needham | BUY | $8.00 |
| 16 Oct 2026 | BofA Securities | HOLD | $6.00 |
| 16 Oct 2026 | Morgan Stanley | HOLD | $5.90 |
| 21 Sep 2026 | BofA Securities | HOLD | – |
| 15 Sep 2026 | J.P. Morgan | BUY | – |
| 17 Aug 2026 | Morgan Stanley | HOLD | $5.30 |
| 12 Aug 2026 | BofA Securities | HOLD | $6.00 |
| 7 Aug 2026 | BofA Securities | HOLD | $6.00 |
| 5 Aug 2026 | TD Cowen | HOLD | – |
| 5 Aug 2026 | Needham | BUY | $8.00 |
| 14 May 2026 | Morgan Stanley | HOLD | $5.50 |
| 13 May 2026 | BofA Securities | HOLD | $6.00 |
| 7 May 2026 | BofA Securities | HOLD | $6.00 |
| 7 May 2026 | Needham | BUY | $8.00 |
| 6 May 2026 | TD Cowen | HOLD | – |
| 30 Apr 2026 | J.P. Morgan | BUY | $10.00 |
| 14 Apr 2026 | Needham | BUY | $8.00 |
| 25 Feb 2026 | TD Cowen | HOLD | – |
| 25 Feb 2026 | BofA Securities | HOLD | $6.00 |
No comments yet — be the first to weigh in on RXRX.
Sign in to join the discussion.